Trial intelligence / Profile preview

Caffeine for postoperative ileus after laparotomy

IRCT20140203016473N11Phase 3Completed

Sponsor
Tabriz University of Medical Sciences
Start
Jan 2021
Modality
Small Molecules
Countries
1
01

Overview

Phase 3, randomised, open-label trial in postoperative ileus (POI) comparing Caffeine with Placebo (2 arms). Primary endpoint: Intestinal movements and sounds. Started Jan 2021; status: completed.

02

Drugs

caffeine
03

Conditions

postoperative ileus (POI)

Beyond the preview

Go deeper on IRCT20140203016473N11.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on IRCT20140203016473N11.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call